Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
- 1 February 2000
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 32 (2) , 300-306
- https://doi.org/10.1016/s0168-8278(00)80076-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudineLiver International, 1997
- Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled TrialHepatology, 1997
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferonJournal of Hepatology, 1992
- Precore mutant hepatitis B virus infection and liver diseaseGastroenterology, 1992
- Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic areaVirology, 1991
- Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.Proceedings of the National Academy of Sciences, 1991
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990
- Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigenHepatology, 1989